Appropriate storage practices help maintain quality throughout the research process
Supergut spoke to leading experts in the field, who lauded these drugs transformative effects as well as unbelievable promise in weight-loss trials
Weight-loss drug semaglutide does not slow Alzheimer's disease The diabetes and weight-loss drug semaglutide is not effective at slowing the progression of Alzheimer's disease, according to a large clinical trial in patients with mild Alzheimer's
Global Glucagon-like Peptide-1 Agonists Market Trends and Insights Drivers Impact Analysis * Rising Prevalence of Type-2 Diabetes International Diabetes Federation projections show diabetes cases climbing from 537 million in 2021 to 783 million by 2045, with 90% classified as type-2 [1]International Diabetes Federation, IDF Diabetes Atlas, 10th Edition, diabetesatlas.org
We also discovered and reported that supplementing GlyNAC (glycine and N-acetylcysteine, as a cysteine donor) in human trials corrected GSH deficiency, OxS and mitochondrial dysfunction, and in HIV-patients it also improved mitophagy, nutrient sensing and lowered genomic damage, and reversed premature aging [29,30]
